购物车
- 全部删除
- 您的购物车当前为空
GSK-J1 lithium salt 是一种有效的 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的抑制剂,对 KDM6B 的 IC50值为 60 nM。
GSK-J1 lithium salt 是一种有效的 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的抑制剂,对 KDM6B 的 IC50值为 60 nM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 4-6周 | |
50 mg | ¥ 13,800 | 4-6周 | |
100 mg | ¥ 17,500 | 4-6周 |
产品描述 | GSK-J1 lithium salt is an effective inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with an IC 50 of 60 nM for KDM6B. |
靶点活性 | JMJD3 (KDM6B):60 nM |
体外活性 | GSK-J1 is selective for H3K27 demethylases of the KDM6 subfamily and specifically binds to endogenous JMJD3. GSK-J1 inhibits TNF-α production by human primary macrophages in an H3K27-dependent manner [1]. GSK-J1 inhibits the demethylase activity of KDM5C with 8.5-fold increased potency than that of KDM5B at 1 mM α-ketoglutarate, with IC 50 of 11 μM and 94 μM, respectively [3]. |
分子量 | 395.38 |
分子式 | C22H22LiN5O2 |
CAS No. | 2309668-29-7 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容